Table 1 Comparative baseline characteristics by Lactate-to-Albumin ratio groups.
LAR (< 0.46) | LAR (0.46–0.81) | LAR (> 0.81) | P | |
|---|---|---|---|---|
N = 1485 | N = 1507 | N = 1512 | ||
LAR | 0.34 [0.28;0.40] | 0.61 [0.53;0.69] | 1.23 [0.97;1.72] | <0.001 |
Lac | 1.11 (0.27) | 1.85 (0.44) | 4.06 (2.02) | <0.001 |
Alb | 3.30 (0.55) | 3.02 (0.58) | 2.78 (0.60) | <0.001 |
Age | 67.0 [57.0;77.0] | 69.0 [60.0;78.0] | 68.0 [59.0;78.0] | 0.001 |
Gender | 0.008 | |||
Female | 626 (42.2%) | 584 (38.8%) | 670 (44.3%) | |
Male | 859 (57.8%) | 923 (61.2%) | 842 (55.7%) | |
Race | 0.161 | |||
Asian | 31 (2.09%) | 41 (2.72%) | 40 (2.65%) | |
Black | 125 (8.42%) | 128 (8.49%) | 145 (9.59%) | |
Hispanic | 46 (3.10%) | 37 (2.46%) | 50 (3.31%) | |
Other | 372 (25.1%) | 333 (22.1%) | 381 (25.2%) | |
White | 911 (61.3%) | 968 (64.2%) | 896 (59.3%) | |
BMI | 29.9 (8.24) | 30.0 (7.86) | 30.0 (7.89) | 0.894 |
WBC | 10.9 [8.10;14.4] | 12.2 [9.00;16.9] | 13.3 [8.90;18.6] | <0.001 |
RBC | 3.70 [3.19;4.23] | 3.56 [3.04;4.14] | 3.45 [2.89;4.10] | <0.001 |
Hb | 11.1 [9.60;12.7] | 10.7 [9.10;12.4] | 10.4 [8.80;12.2] | <0.001 |
Cr | 0.90 [0.70;1.20] | 1.00 [0.80;1.30] | 1.10 [0.80;1.60] | <0.001 |
BUN | 17.0 [13.0;26.0] | 20.0 [14.0;30.0] | 21.0 [14.0;33.0] | <0.001 |
Na | 138 [136;141] | 139 [136;141] | 139 [135;141] | 0.424 |
K | 4.00 [3.70;4.40] | 4.10 [3.70;4.60] | 4.20 [3.70;4.70] | <0.001 |
Calcium | 8.40 [7.90;8.90] | 8.20 [7.70;8.70] | 8.10 [7.60;8.60] | <0.001 |
PLT | 204 [148;270] | 189 [132;261] | 164 [110;238] | <0.001 |
Cancer: | 0.478 | |||
No | 1264 (85.1%) | 1263 (83.8%) | 1289 (85.3%) | |
Yes | 221 (14.9%) | 244 (16.2%) | 223 (14.7%) | |
CKD | 0.459 | |||
No | 1469 (98.9%) | 1492 (99.0%) | 1490 (98.5%) | |
Yes | 16 (1.08%) | 15 (1.00%) | 22 (1.46%) | |
AKI | <0.001 | |||
No | 955 (64.3%) | 862 (57.2%) | 676 (44.7%) | |
Yes | 530 (35.7%) | 645 (42.8%) | 836 (55.3%) | |
T2DM | 0.013 | |||
No | 1078 (72.6%) | 1025 (68.0%) | 1038 (68.7%) | |
Yes | 407 (27.4%) | 482 (32.0%) | 474 (31.3%) | |
COPD | 0.001 | |||
No | 1230 (82.8%) | 1269 (84.2%) | 1325 (87.6%) | |
Yes | 255 (17.2%) | 238 (15.8%) | 187 (12.4%) | |
MI | 0.729 | |||
No | 1363 (91.8%) | 1386 (92.0%) | 1379 (91.2%) | |
Yes | 122 (8.22%) | 121 (8.03%) | 133 (8.80%) | |
HF | 0.076 | |||
No | 1218 (82.0%) | 1212 (80.4%) | 1264 (83.6%) | |
Yes | 267 (18.0%) | 295 (19.6%) | 248 (16.4%) | |
SOFA | 4.00 [2.00;7.00] | 5.00 [3.00;8.00] | 8.00 [5.00;10.0] | <0.001 |
SAPSII | 35.0 [28.0;43.0] | 39.0 [31.0;48.0] | 44.0 [35.0;54.2] | <0.001 |
GCS | 15.0 [13.0;15.0] | 15.0 [14.0;15.0] | 15.0 [14.0;15.0] | 0.446 |
Glucocorticoids | 0.135 | |||
Yes | 417 (28.1%) | 392 (26.0%) | 442 (29.2%) | |
No | 1068 (71.9%) | 1115 (74.0%) | 1070 (70.8%) | |
Antihypertensive | 0.301 | |||
Yes | 1206 (81.2%) | 1256 (83.3%) | 1239 (81.9%) | |
No | 279 (18.8%) | 251 (16.7%) | 273 (18.1%) | |
Nbpm | 83.0 [72.0;97.0] | 80.0 [69.0;94.0] | 77.0 [66.0;91.0] | <0.001 |
RR | 18.0 [15.0;22.0] | 19.0 [15.0;23.0] | 19.0 [15.0;24.0] | 0.435 |
Spo2 | 98.0 [95.0;100] | 99.0 [96.0;100] | 99.0 [95.0;100] | <0.001 |
Temperaturef | 98.3 [97.7;99.0] | 98.3 [97.7;98.9] | 98.2 [97.6;98.9] | 0.001 |
OS | 28.0 [28.0;28.0] | 28.0 [28.0;28.0] | 28.0 [16.5;28.0] | <0.001 |
Death | <0.001 | |||
No | 1242 (83.6%) | 1186 (78.7%) | 1095 (72.4%) | |
Yes | 243 (16.4%) | 321 (21.3%) | 417 (27.6%) |